• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算 2020/21 年英格兰大肠埃希菌菌血症的发病率和 30 天全因死亡率。

Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21.

机构信息

Healthcare Associated Infections and Antimicrobial Resistance, Public Health England, London, UK.

Healthcare Associated Infections and Antimicrobial Resistance, Public Health England, London, UK.

出版信息

J Hosp Infect. 2018 Mar;98(3):228-231. doi: 10.1016/j.jhin.2017.09.021. Epub 2017 Sep 30.

DOI:10.1016/j.jhin.2017.09.021
PMID:28974468
Abstract

Escherichia coli bacteraemia rates have been increasing in England. Using the national mandatory surveillance data for E. coli bacteraemia from 2012/13 to 2016/17, we aimed to estimate the incidence of E. coli bacteraemia and 30-day all-cause case fatality rate (CFR) by 2020/21 in the absence of new interventions to reduce infection rates. After controlling for age, sex, and hospital versus community-onset of infection, it is estimated that the incidence of E. coli bacteraemia will be 90.5 (95% PI: 89.8-91.3) per 100,000 population (N = 50,663), with an associated CFR of 11.5 (95% PI: 11.2-11.8) per 100,000 population (N = 6554), by 2020/21.

摘要

英格兰的大肠杆菌菌血症发病率一直在上升。利用 2012/13 至 2016/17 年全国强制性大肠杆菌菌血症监测数据,我们旨在估算在没有新干预措施降低感染率的情况下,到 2020/21 年大肠杆菌菌血症的发病率和 30 天全因病死率(CFR)。在控制年龄、性别和医院与社区感染的发病情况后,预计到 2020/21 年,每 10 万人中将有 90.5 例(95%置信区间:89.8-91.3)大肠杆菌菌血症(N=50663),相应的病死率为每 10 万人中有 11.5 例(95%置信区间:11.2-11.8)(N=6554)。

相似文献

1
Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21.估算 2020/21 年英格兰大肠埃希菌菌血症的发病率和 30 天全因死亡率。
J Hosp Infect. 2018 Mar;98(3):228-231. doi: 10.1016/j.jhin.2017.09.021. Epub 2017 Sep 30.
2
Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.英格兰产大肠埃希菌菌血症患者的 30 天全因死亡率。
Clin Microbiol Infect. 2015 Mar;21(3):251.e1-8. doi: 10.1016/j.cmi.2015.01.001. Epub 2015 Jan 14.
3
Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.2012年4月至2014年3月英格兰大肠杆菌菌血症的描述性流行病学
Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30329.
4
Identifying hospital-onset Escherichia coli bacteraemia cases from English mandatory surveillance: the case for applying a two-day post-admission rule.从英文强制性监测中识别医院获得性大肠杆菌菌血症病例:应用两天入院后规则的理由。
J Hosp Infect. 2017 Nov;97(3):207-211. doi: 10.1016/j.jhin.2017.06.031. Epub 2017 Jul 4.
5
Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.影响大肠埃希菌菌血症负担的因素:2011-2015 年伦敦西部多变量回归分析数据
J Hosp Infect. 2019 Feb;101(2):120-128. doi: 10.1016/j.jhin.2018.10.024. Epub 2018 Nov 4.
6
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.加拿大一个大区域内大肠杆菌血流感染的发病率、危险因素及转归
Clin Microbiol Infect. 2008 Nov;14(11):1041-7. doi: 10.1111/j.1469-0691.2008.02089.x.
7
Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.大肠杆菌血流感染的死亡率:一项基于多国人群的队列研究。
BMC Infect Dis. 2021 Jun 25;21(1):606. doi: 10.1186/s12879-021-06326-x.
8
Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.产超广谱β-内酰胺酶大肠埃希菌引起的社区获得性菌血症的危险因素和治疗结局。
Int J Antimicrob Agents. 2010 Sep;36(3):284-7. doi: 10.1016/j.ijantimicag.2010.05.009. Epub 2010 Jun 30.
9
Escherichia coli bacteraemia in Canberra: incidence and clinical features.堪培拉地区大肠杆菌败血症:发病率及临床特征
Med J Aust. 2008 Feb 18;188(4):209-13. doi: 10.5694/j.1326-5377.2008.tb01586.x.
10
Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.社区获得性大肠杆菌菌血症中医疗保健相关感染的临床意义
J Antimicrob Chemother. 2007 Dec;60(6):1355-60. doi: 10.1093/jac/dkm378. Epub 2007 Oct 8.

引用本文的文献

1
Preventing and managing urinary tract infections: Exploring interventions and strategies implemented by NHS commissioning organisations in English primary care, 2017-2022.预防和管理尿路感染:探索英国国家医疗服务体系委托机构在2017 - 2022年英国初级医疗保健中实施的干预措施和策略。
J Infect Prev. 2025 Mar 29:17571774251330536. doi: 10.1177/17571774251330536.
2
Epidemiology of invasive disease in adults in England, 2013-2017.2013 - 2017年英格兰成人侵袭性疾病的流行病学
Epidemiol Infect. 2025 Jan 6;153:e4. doi: 10.1017/S0950268824001584.
3
A convergent evolutionary pathway attenuating cellulose production drives enhanced virulence of some bacteria.
一种趋同进化途径削弱了纤维素的产生,从而增强了一些细菌的毒力。
Nat Commun. 2024 Feb 21;15(1):1441. doi: 10.1038/s41467-024-45176-4.
4
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria.整合组学鉴定出导致脓毒症的细菌的保守和病原体特异性反应。
Nat Commun. 2023 Mar 18;14(1):1530. doi: 10.1038/s41467-023-37200-w.
5
E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.社区抗菌药物治疗尿路感染后大肠埃希菌菌血症和抗菌药物耐药性
BMC Infect Dis. 2022 Oct 28;22(1):805. doi: 10.1186/s12879-022-07768-7.
6
Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.产肠杆菌科细菌血流感染不良预后的细菌基因型和患者危险因素:一项前瞻性分子流行病学研究。
J Antimicrob Chemother. 2022 May 29;77(6):1753-1761. doi: 10.1093/jac/dkac071.
7
Surviving Serum: the Escherichia coli Gene of Extraintestinal Pathogenic E. coli Is Required for the Synthesis of Group 4 Capsule.存活血清:肠外致病性大肠杆菌的大肠杆菌基因是合成 4 组荚膜所必需的。
Infect Immun. 2021 Sep 16;89(10):e0031621. doi: 10.1128/IAI.00316-21. Epub 2021 Jun 28.
8
Biocidal Resistance in Clinically Relevant Microbial Species: A Major Public Health Risk.临床相关微生物物种中的抗微生物剂耐药性:一项重大的公共卫生风险。
Pathogens. 2021 May 14;10(5):598. doi: 10.3390/pathogens10050598.
9
Realising the broader value of vaccines in the UK.认识到疫苗在英国更广泛的价值。
Vaccine X. 2021 Apr 6;8:100096. doi: 10.1016/j.jvacx.2021.100096. eCollection 2021 Aug.
10
Diagnosis and Management of UTI in Primary Care Settings-A Qualitative Study to Inform a Diagnostic Quick Reference Tool for Women Under 65 Years.基层医疗环境中尿路感染的诊断与管理——一项定性研究,为65岁以下女性提供诊断快速参考工具
Antibiotics (Basel). 2020 Sep 7;9(9):581. doi: 10.3390/antibiotics9090581.